Fundraising Fox

Tr1X Bio

2 known investors

Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

D
DavidCo-Founder
MG
Maria Grazia RoncaroloCo-Founder, President and Head of R&D

Investors · 2

Neva Sgr.Turin
The Column GroupSan Francisco · $30M

In the news

Impact - Tr1X Biotr1x.bio · Feb 2026Tr1X Bio Lands IND Nod, $50M - San Diego Business Journalsdbj.com · Oct 2025Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases - Tr1X Biotr1x.bio · Jan 2024

Frequently asked questions

What does Tr1X Bio do?
Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.
Who founded Tr1X Bio?
Tr1X Bio was founded by David, Maria Grazia Roncarolo.
Who are Tr1X Bio's investors?
Tr1X Bio's investors include Neva Sgr., The Column Group.